GLYCOGENIC ACANTHOSIS

This adverse event was reported 9 times

GLYCOGENIC ACANTHOSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 IBANDRONATE SODIUM 2 0.0006
1 TEDUGLUTIDE 2 0.0001
2 URSOSIOL 2 0.0001
3 URSODIOL 2 0.0001
4 PANTOPRAZOLE SODIUM INJECTION 2 0.0000
5 EVEROLIMUS 1 0.0000
6 USTEKINUMAB 2 0.0000
7 DAPAGLIFLOZIN 1 0.0000
8 FINASTERIDE 1 0.0000
9 RAMIPRIL 2 0.0000
See all drugs enriched for association with GLYCOGENIC ACANTHOSIS